NEW YORK (360Dx) – With its recent buy of ApoCell and its circulating tumor cell enrichment technology, Precision for Medicine aims to continue its expansion into the liquid biopsy market.
Further Expansion Into Liquid Biopsy Space Eyed by Precision for Medicine With Recent Acquisition
Premium
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.